Prencillo, Venishia Kaye N.

HRN: 24-92-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
CEFUROXIME 750MG (VIAL)
04/06/2024
04/13/2024
IV
350 Mg
Q8
PCAP-C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: